The molecular docking assay focuses on specific receptors such as human inducible nitric oxide synthase (iNOS), human pancreatic lipase, human reactive oxygen species (ROS) 1 kinase, and fat mass and obesity-associated (FTO) proteins. The gene discussed is NOS2; the disease is obesity disorder.